Carisoprodol

Product NDC: 52959-026
11-digit product format: 529590026
Labeler code: 52959
Product ID: 52959-026_8baadcf8-d2c4-40c6-9fa0-485a0d699745
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Carisoprodol
Dosage form: TABLET
Route: ORAL
Labeler: H.J. Harkins Company, Inc.
Application: ANDA040124
Marketing category: ANDA
Marketing start: 1996-01-24
Marketing end: 0000-00-00
Substance: CARISOPRODOL
Active strength: 350 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA schedule: CIV
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 24 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52959-026		I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-00	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-03	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-06	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-10	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-12	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-14	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-15	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-20	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-21	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-24	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-25	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-28	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-30	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-32	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-40	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-42	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-45	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-50	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-52	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-56	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-60	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-80	I	Inactivated by FDA	2026-08-17
excluded package	package	52959-026	52959-026-90	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 9 · 528 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-90	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-24	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-42	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-56	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-15	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-12	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-06	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-40	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-21	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-52	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-25	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-14	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-32	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-45	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-026-80	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-90	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-24	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-42	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-56	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-15	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-12	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-06	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-40	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-21	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-52	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-25	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-14	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-32	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-45	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-026-80	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-90	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-24	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-42	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-56	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-15	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-12	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-026-06	`2ef7874e63bc…`	`57b86245f4fa…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040124-001	CARISOPRODOL	CARISOPRODOL	350MG	TABLET / ORAL			1996-01-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	1996-01-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	1996-01-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	1996-01-24	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	1996-01-24	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040124-001	CARISOPRODOL	350MG	TABLET / ORAL		1996-01-24	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A040124-001	AA	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A040124-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040124-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040124-001	AA	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
780d53a1-1665-e26e-d112-85333c0c8a2e	Product name	5	20220516
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
52959-026-00	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-03	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-06	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-10	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-12	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-14	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-15	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-20	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-21	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-24	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-25	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-28	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-30	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-32	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-40	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-42	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-45	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-50	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-52	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-56	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-60	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-80	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959
52959-026-90	Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
52959-026-30	Prazolamine	30 in 1 BOTTLE	TABLET	30	350 mg	18
52959-026-00	Carisoprodol	100 in 1 BOTTLE, PLASTIC	TABLET	100		4
52959-026-03	Carisoprodol	120 in 1 BOTTLE, PLASTIC	TABLET	120		4
52959-026-06	Carisoprodol	06 in 1 BOTTLE, PLASTIC	TABLET	06		4
52959-026-10	Carisoprodol	10 in 1 BOTTLE, PLASTIC	TABLET	10		4
52959-026-12	Carisoprodol	12 in 1 BOTTLE, PLASTIC	TABLET	12		4
52959-026-14	Carisoprodol	14 in 1 BOTTLE, PLASTIC	TABLET	14		4
52959-026-15	Carisoprodol	15 in 1 BOTTLE, PLASTIC	TABLET	15		4
52959-026-20	Carisoprodol	20 in 1 BOTTLE, PLASTIC	TABLET	20		4
52959-026-21	Carisoprodol	21 in 1 BOTTLE, PLASTIC	TABLET	21		4
52959-026-24	Carisoprodol	24 in 1 BOTTLE, PLASTIC	TABLET	24		4
52959-026-25	Carisoprodol	25 in 1 BOTTLE, PLASTIC	TABLET	25		4
52959-026-28	Carisoprodol	28 in 1 BOTTLE, PLASTIC	TABLET	28		4
52959-026-30	Carisoprodol	30 in 1 BOTTLE, PLASTIC	TABLET	30		4
52959-026-32	Carisoprodol	32 in 1 BOTTLE, PLASTIC	TABLET	32		4
52959-026-40	Carisoprodol	40 in 1 BOTTLE, PLASTIC	TABLET	40		4
52959-026-42	Carisoprodol	42 in 1 BOTTLE, PLASTIC	TABLET	42		4
52959-026-45	Carisoprodol	45 in 1 BOTTLE, PLASTIC	TABLET	45		4
52959-026-50	Carisoprodol	50 in 1 BOTTLE, PLASTIC	TABLET	50		4
52959-026-52	Carisoprodol	52 in 1 BOTTLE, PLASTIC	TABLET	52		4
52959-026-56	Carisoprodol	56 in 1 BOTTLE, PLASTIC	TABLET	56		4
52959-026-60	Carisoprodol	60 in 1 BOTTLE, PLASTIC	TABLET	60		4
52959-026-80	Carisoprodol	80 in 1 BOTTLE, PLASTIC	TABLET	80		4
52959-026-90	Carisoprodol	90 in 1 BOTTLE, PLASTIC	TABLET	90		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52959-026-00	EA - Each	52959-026	aa9e7613-0364-48e7-8472-596ec75b38a2	1	2012-07-24
52959-026-03	EA - Each	52959-026	5b9256b5-547e-400b-b136-bf088e14c3f9	1	2012-07-24
52959-026-06	EA - Each	52959-026	952d3d9f-2104-4488-8c8a-de0ed539ee75	1	2012-07-24
52959-026-10	EA - Each	52959-026	42ca42d0-6d81-434c-9414-eaef4871095e	1	2012-07-24
52959-026-12	EA - Each	52959-026	3aed03e1-abb6-4893-aed5-30892e842429	1	2012-07-24
52959-026-14	EA - Each	52959-026	31686109-9d91-4e87-b560-3520649f65e1	1	2012-07-24
52959-026-15	EA - Each	52959-026	db540f51-ef3f-4ef4-95b5-f9bf0c09796e	1	2012-07-24
52959-026-20	EA - Each	52959-026	b9b15167-ec56-4bc1-b47e-633a2c612172	1	2012-07-24
52959-026-21	EA - Each	52959-026	2e58ba18-31d9-484b-8889-494165c08da4	1	2012-07-24
52959-026-24	EA - Each	52959-026	e44bd27a-8517-41c2-9245-0f285e10c6ad	1	2012-07-24
52959-026-25	EA - Each	52959-026	e2c16149-679e-421f-99c0-a19022d8d8ed	1	2012-07-24
52959-026-28	EA - Each	52959-026	3547d6dd-50b8-4b51-ba13-057c10947bc1	1	2012-07-24
52959-026-30	EA - Each	52959-026	16df71d0-31a5-41b2-b4d4-49ae32b1cd0b	1	2012-07-24
52959-026-32	EA - Each	52959-026	b8688fc1-1b49-4681-ac3d-f16ef3ed4ba9	1	2012-07-24
52959-026-40	EA - Each	52959-026	4851b539-aea3-4ad3-87f0-8bb311d118d1	1	2012-07-24
52959-026-45	EA - Each	52959-026	a6e8258c-6fce-42ea-85be-66c7be282770	1	2012-07-24
52959-026-50	EA - Each	52959-026	0a2fa3d2-8773-46d5-ba85-547f34fad348	1	2012-07-24
52959-026-52	EA - Each	52959-026	d23d85e1-beff-4c82-bdbe-c159fd50a886	1	2012-07-24
52959-026-56	EA - Each	52959-026	1cea57c5-1317-4e25-aa7c-42c63c231489	1	2012-07-24
52959-026-60	EA - Each	52959-026	c371f0b4-ec7a-4975-a862-f0f8dd42fadc	1	2012-07-24
52959-026-80	EA - Each	52959-026	1d24fb2e-ff7a-401d-8063-f4134eb2f87f	1	2012-07-24
52959-026-90	EA - Each	52959-026	b2ab64bb-d684-495a-8731-7be0826bcfcb	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
.GAMMA.-AMINOBUTYRIC ACID	ACTIVE INGREDIENT	2ACZ6IPC6I	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
CARISOPRODOL	ACTIVE INGREDIENT	21925K482H	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
.GAMMA.-AMINOBUTYRIC ACID	ACTIVE MOIETY	2ACZ6IPC6I	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
CARISOPRODOL	ACTIVE MOIETY	21925K482H	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18
CARISOPRODOL	ACTIVE INGREDIENT	21925K482H	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
CARISOPRODOL	ACTIVE MOIETY	21925K482H	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
METHYLCELLULOSE (100 CPS)	INACTIVE INGREDIENT	4GFU244C4J	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52959-026	PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]	18	Legacy NDC	20110812_99265e39-af23-43eb-a552-305f0a218fdf.zip
52959-026	CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]	4	Legacy NDC, 23 package rows	20120919_037618dc-8aed-4a96-93a5-69971f2a3742.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
21925K482H	CARISOPRODOL	78-44-4	CARISOPRODOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197446	carisoprodol 350 MG Oral Tablet	PSN	99265e39-af23-43eb-a552-305f0a218fdf	18
197446	carisoprodol 350 MG Oral Tablet	SCD	99265e39-af23-43eb-a552-305f0a218fdf	18
197446	carisoprodol 350 MG Oral Tablet	PSN	037618dc-8aed-4a96-93a5-69971f2a3742	4
197446	carisoprodol 350 MG Oral Tablet	SCD	037618dc-8aed-4a96-93a5-69971f2a3742	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
52959-026-00	52959002600	100 in 1 BOTTLE, PLASTIC	Historical
52959-026-03	52959002603	120 in 1 BOTTLE, PLASTIC	Historical
52959-026-06	52959002606	06 in 1 BOTTLE, PLASTIC	Historical
52959-026-10	52959002610	10 in 1 BOTTLE, PLASTIC	Historical
52959-026-12	52959002612	12 in 1 BOTTLE, PLASTIC	Historical
52959-026-14	52959002614	14 in 1 BOTTLE, PLASTIC	Historical
52959-026-15	52959002615	15 in 1 BOTTLE, PLASTIC	Historical
52959-026-20	52959002620	20 in 1 BOTTLE, PLASTIC	Historical
52959-026-21	52959002621	21 in 1 BOTTLE, PLASTIC	Historical
52959-026-24	52959002624	24 in 1 BOTTLE, PLASTIC	Historical
52959-026-25	52959002625	25 in 1 BOTTLE, PLASTIC	Historical
52959-026-28	52959002628	28 in 1 BOTTLE, PLASTIC	Historical
52959-026-30	52959002630	30 in 1 BOTTLE	Historical
52959-026-32	52959002632	32 in 1 BOTTLE, PLASTIC	Historical
52959-026-40	52959002640	40 in 1 BOTTLE, PLASTIC	Historical
52959-026-42	52959002642	42 in 1 BOTTLE, PLASTIC	Historical
52959-026-45	52959002645	45 in 1 BOTTLE, PLASTIC	Historical
52959-026-50	52959002650	50 in 1 BOTTLE, PLASTIC	Historical
52959-026-52	52959002652	52 in 1 BOTTLE, PLASTIC	Historical
52959-026-56	52959002656	56 in 1 BOTTLE, PLASTIC	Historical
52959-026-60	52959002660	60 in 1 BOTTLE, PLASTIC	Historical
52959-026-80	52959002680	80 in 1 BOTTLE, PLASTIC	Historical
52959-026-90	52959002690	90 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Carisoprodol	H.J. Harkins Company, Inc. \| West-ward Pharmaceutical Corp	2012-09-18	HUMAN PRESCRIPTION DRUG LABEL	4
Prazolamine	Physician Therapeutics LLC \| West-ward Pharmaceutical Corp \| H.J. Harkins Company, Inc. \| Targeted Medical Pharma Inc.	2011-08-01	HUMAN PRESCRIPTION DRUG LABEL	18